Tumor pain

Known as: pain tumor, pain tumors 
A painful sensation caused by the tumor growth.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1966-2016
0519662016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
PURPOSE Preclinical studies show that OXi4503 (combretastatin A1 diphosphate, CA1P) is more potent than other clinically… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2011
2011
Bone tumor pain is a poorly controlled pain comprising background and severe pain on moving or weight-bearing postures that… (More)
Is this relevant?
2009
2009
Interleukin-6 (IL-6) is a key mediator of inflammation. Inhibitors of IL-6 or of its signal transducing receptor gp130 constitute… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
PURPOSE We conducted a first-in-man (to our knowledge) phase I study to determine the dose-limiting toxicities (DLTs… (More)
Is this relevant?
2004
2004
Purpose: To test the activity of the cyclin dependent kinase (cdk) inhibitor flavopiridol in malignant melanoma, a disease with… (More)
  • table 2
  • table 4
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE A phase I trial was performed with combretastatin A4 phosphate (CA4P), a novel tubulin-binding agent that has been shown… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Combretastatin A-4 phosphate (CA4P) is a novel antitumor vascular targeting agent, the first agent of this class of compounds to… (More)
  • figure 2
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2002
2002
PURPOSE To define the maximum-tolerated dose (MTD), dose-limiting toxicity, and pharmacokinetics of the cyclin-dependent kinase… (More)
Is this relevant?
2001
2001
Vinorelbine is a synthetic vinca alkaloid used for the treatment of Hodgkin's disease and metastatic breast, non-small-cell lung… (More)
Is this relevant?
1987
1987
The prevalence and nature of pain in the population of children and young adults with malignancy treated by the Pediatric Branch… (More)
Is this relevant?